Predict your next investment

Private Equity
lakebleu-cap.com

See what CB Insights has to offer

Investments

31

Portfolio Exits

8

About Lake Bleu Capital

Lake Bleu Capital is a private equity firm based in Hong Kong that invests in healthcare.

Lake Bleu Capital Headquarter Location

Hong Kong

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Lake Bleu Capital News

Broncus Holding Company Closes Series C Financing

Nov 5, 2020

Broncus Holding Company , a Hangzhou, China-based global leader in diagnostic and therapeutic technology for lung diseases, closed a Series C round of funding. The round was led by Lake Bleu Capital, with participation from Baidu Capital, Ascendum Capital, CNCB Capital and DCP Capital, along with previous investor Qiming Venture Capital. The funds will be used to further develop markets and technology across lung cancer, emphysema and other important lung diseases. Founded in 2012 and led by CEO Zhan Guowei, Broncus is dedicated to the development of diagnostic and therapeutic technology for lung disease. The company’s primary technology platforms focus on the diagnosis of lung cancer and the treatment of emphysema. Its lung cancer portfolio includes the Archimedes® System, Archimedes® Planner, LungPoint® Virtual Bronchoscopic Navigation (VBN) System, LungPoint® Planner and FleXNeedle®. The Archimedes System has been cleared by the FDA (U.S.), CE (Europe) and NMPA (China) and had broad patent protection globally. The InterVapor System has received the CE Mark. FinSMEs 04/11/2020

Lake Bleu Capital Investments

31 Investments

Lake Bleu Capital has made 31 investments. Their latest investment was in Bangbang Robot as part of their Series B on June 6, 2022.

CBI Logo

Lake Bleu Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/30/2022

Series B

Bangbang Robot

$14.9M

Yes

2

4/11/2022

Series A - II

Synthegene

$47.1M

Yes

1

1/25/2022

Series D - II

Tongxin Medical

No

1

12/31/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

11/24/2021

Series C

Subscribe to see more

Subscribe to see more

10

Date

6/30/2022

4/11/2022

1/25/2022

12/31/2021

11/24/2021

Round

Series B

Series A - II

Series D - II

Series C

Series C

Company

Bangbang Robot

Synthegene

Tongxin Medical

Subscribe to see more

Subscribe to see more

Amount

$14.9M

$47.1M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

1

10

10

Lake Bleu Capital Portfolio Exits

8 Portfolio Exits

Lake Bleu Capital has 8 portfolio exits. Their latest portfolio exit was Ruike Biotechnology on March 31, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/31/2022

IPO

$99M

Public

1

11/5/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

10/13/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

9/24/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

7/13/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/31/2022

11/5/2021

10/13/2021

9/24/2021

7/13/2021

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.